257 related articles for article (PubMed ID: 20096356)
1. Dominant connexin26 mutants associated with human hearing loss have trans-dominant effects on connexin30.
Yum SW; Zhang J; Scherer SS
Neurobiol Dis; 2010 May; 38(2):226-36. PubMed ID: 20096356
[TBL] [Abstract][Full Text] [Related]
2. Dominant Cx26 mutants associated with hearing loss have dominant-negative effects on wild type Cx26.
Zhang J; Scherer SS; Yum SW
Mol Cell Neurosci; 2011 Jun; 47(2):71-8. PubMed ID: 21040787
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the gene for connexin 26 (GJB2) that cause hearing loss have a dominant negative effect on connexin 30.
Marziano NK; Casalotti SO; Portelli AE; Becker DL; Forge A
Hum Mol Genet; 2003 Apr; 12(8):805-12. PubMed ID: 12668604
[TBL] [Abstract][Full Text] [Related]
4. Human connexin26 and connexin30 form functional heteromeric and heterotypic channels.
Yum SW; Zhang J; Valiunas V; Kanaporis G; Brink PR; White TW; Scherer SS
Am J Physiol Cell Physiol; 2007 Sep; 293(3):C1032-48. PubMed ID: 17615163
[TBL] [Abstract][Full Text] [Related]
5. Induction of cell death and gain-of-function properties of connexin26 mutants predict severity of skin disorders and hearing loss.
Press ER; Shao Q; Kelly JJ; Chin K; Alaga A; Laird DW
J Biol Chem; 2017 Jun; 292(23):9721-9732. PubMed ID: 28428247
[TBL] [Abstract][Full Text] [Related]
6. The inner ear contains heteromeric channels composed of cx26 and cx30 and deafness-related mutations in cx26 have a dominant negative effect on cx30.
Forge A; Marziano NK; Casalotti SO; Becker DL; Jagger D
Cell Commun Adhes; 2003; 10(4-6):341-6. PubMed ID: 14681039
[TBL] [Abstract][Full Text] [Related]
7. Intracellular domains of mouse connexin26 and -30 affect diffusional and electrical properties of gap junction channels.
Manthey D; Banach K; Desplantez T; Lee CG; Kozak CA; Traub O; Weingart R; Willecke K
J Membr Biol; 2001 May; 181(2):137-48. PubMed ID: 11420600
[TBL] [Abstract][Full Text] [Related]
8. Early developmental expression of connexin26 in the cochlea contributes to its dominate functional role in the cochlear gap junctions.
Qu Y; Tang W; Zhou B; Ahmad S; Chang Q; Li X; Lin X
Biochem Biophys Res Commun; 2012 Jan; 417(1):245-50. PubMed ID: 22142852
[TBL] [Abstract][Full Text] [Related]
9. trans-dominant inhibition of connexin-43 by mutant connexin-26: implications for dominant connexin disorders affecting epidermal differentiation.
Rouan F; White TW; Brown N; Taylor AM; Lucke TW; Paul DL; Munro CS; Uitto J; Hodgins MB; Richard G
J Cell Sci; 2001 Jun; 114(Pt 11):2105-13. PubMed ID: 11493646
[TBL] [Abstract][Full Text] [Related]
10. The human deafness-associated connexin 30 T5M mutation causes mild hearing loss and reduces biochemical coupling among cochlear non-sensory cells in knock-in mice.
Schütz M; Scimemi P; Majumder P; De Siati RD; Crispino G; Rodriguez L; Bortolozzi M; Santarelli R; Seydel A; Sonntag S; Ingham N; Steel KP; Willecke K; Mammano F
Hum Mol Genet; 2010 Dec; 19(24):4759-73. PubMed ID: 20858605
[TBL] [Abstract][Full Text] [Related]
11. A deafness mechanism of digenic Cx26 (GJB2) and Cx30 (GJB6) mutations: Reduction of endocochlear potential by impairment of heterogeneous gap junctional function in the cochlear lateral wall.
Mei L; Chen J; Zong L; Zhu Y; Liang C; Jones RO; Zhao HB
Neurobiol Dis; 2017 Dec; 108():195-203. PubMed ID: 28823936
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of transcription factor Brn4 disrupts cochlear gap junction plaques in a model of DFN3 non-syndromic deafness.
Kidokoro Y; Karasawa K; Minowa O; Sugitani Y; Noda T; Ikeda K; Kamiya K
PLoS One; 2014; 9(9):e108216. PubMed ID: 25259580
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics of hearing impairment due to mutations in gap junction genes encoding beta connexins.
Rabionet R; Gasparini P; Estivill X
Hum Mutat; 2000 Sep; 16(3):190-202. PubMed ID: 10980526
[TBL] [Abstract][Full Text] [Related]
14. Mutation R184Q of connexin 26 in hearing loss patients has a dominant-negative effect on connexin 26 and connexin 30.
Su CC; Li SY; Su MC; Chen WC; Yang JJ
Eur J Hum Genet; 2010 Sep; 18(9):1061-4. PubMed ID: 20442751
[TBL] [Abstract][Full Text] [Related]
15. Degradation and modification of cochlear gap junction proteins in the early development of age-related hearing loss.
Tajima S; Danzaki K; Ikeda K; Kamiya K
Exp Mol Med; 2020 Jan; 52(1):166-175. PubMed ID: 31988333
[TBL] [Abstract][Full Text] [Related]
16. Frequencies of gap- and tight-junction mutations in Turkish families with autosomal-recessive non-syndromic hearing loss.
Uyguner O; Emiroglu M; Uzumcu A; Hafiz G; Ghanbari A; Baserer N; Yuksel-Apak M; Wollnik B
Clin Genet; 2003 Jul; 64(1):65-9. PubMed ID: 12791041
[TBL] [Abstract][Full Text] [Related]
17. Mice with conditional deletion of Cx26 exhibit no vestibular phenotype despite secondary loss of Cx30 in the vestibular end organs.
Lee MY; Takada T; Takada Y; Kappy MD; Beyer LA; Swiderski DL; Godin AL; Brewer S; King WM; Raphael Y
Hear Res; 2015 Oct; 328():102-12. PubMed ID: 26232528
[TBL] [Abstract][Full Text] [Related]
18. Analysis of trafficking, stability and function of human connexin 26 gap junction channels with deafness-causing mutations in the fourth transmembrane helix.
Ambrosi C; Walker AE; Depriest AD; Cone AC; Lu C; Badger J; Skerrett IM; Sosinsky GE
PLoS One; 2013; 8(8):e70916. PubMed ID: 23967136
[TBL] [Abstract][Full Text] [Related]
19. Distinct and gradient distributions of connexin26 and connexin30 in the cochlear sensory epithelium of guinea pigs.
Zhao HB; Yu N
J Comp Neurol; 2006 Nov; 499(3):506-18. PubMed ID: 16998915
[TBL] [Abstract][Full Text] [Related]
20.
Beach R; Abitbol JM; Allman BL; Esseltine JL; Shao Q; Laird DW
Front Cell Dev Biol; 2020; 8():215. PubMed ID: 32300592
[No Abstract] [Full Text] [Related]
[Next] [New Search]
